Who is the CEO of NanoenTek?

According to the DART company overview, NanoenTek's representative director is 정찬일 (name as registered in Korean). The company was founded on 1987-11-18.

Where is NanoenTek listed?

NanoenTek trades on the Korea Exchange KOSDAQ market under the ticker 039860. Its fiscal year ends in December.

Does NanoenTek pay a dividend?

NanoenTek did not pay a cash dividend for fiscal 2025, according to its annual report.

Which companies are in the same industry as NanoenTek?

Under the Korean Standard Industrial Classification recorded on DART, NanoenTek is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.

NanoenTek KRX:039860KOSDAQ

나노엔텍 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days2

DART filings, 7 days0

Articles tracked2since Sep 11

In Q2 2026, NanoenTek reported revenue of ₩12.5bn, up 39.4% year on year, and operating profit of ₩687m. NanoenTek (나노엔텍) appeared in 2 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 24 with 2 articles. It was most often mentioned alongside Kakao Games, DK Tech and Samsung Electronics.

NanoenTek quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩12.5bn	+39.4%	₩687m margin 5.5%	₩2.1bn
Q1 2026	₩10.5bn	+31.7%	₩149m margin 1.4%	₩1.4bn
Q4 2025 derived	₩12.6bn	+36.7%	₩909m margin 7.2%	₩1.7bn
Q3 2025	₩8.6bn	+8.1%	−₩65m margin −0.8%	₩633m
Q2 2025	₩9.0bn	+33.6%	₩176m margin 2.0%	−₩1.1bn
Q1 2025	₩8.0bn	+20.9%	₩82m margin 1.0%	₩374m
Q4 2024 derived	₩9.3bn	+14.3%	₩457m margin 4.9%	₩2.8bn
Q3 2024	₩7.9bn	+23.4%	₩231m margin 2.9%	−₩276m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

NanoenTek top stories 2 weeks, by number of outlets

1
[여의도 투자본부 2부] 디케이티 vs 나노엔텍 vs 카카오게임즈 vs 삼성전자, 공략법은?
2 outlets · 2 articlesFirst report Oct 24 12:23 MTNSamsung Electronics DK Tech Kakao Games

Latest NanoenTek news Korean headlines

Oct 2412:23
[여의도 투자본부 2부] 디케이티 vs 나노엔텍 vs 카카오게임즈 vs 삼성전자, 공략법은?
MTNSamsung Electronics DK Tech Kakao Games
1 more on this story · 1 outlets
- [여의도 투자본부 2부] 디케이티 vs 나노엔텍 vs 카카오게임즈 vs 삼성전자, 공략법은?머니투데이 · Oct 24 12:44

Articles per day 2 weeks

224

Company profile

CEO: 정찬일
Industry: Medical devices
Founded: 1987-11-18
Fiscal year-end: December
Head office: 서울특별시 구로구
Website: nanoentek.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
Seers	₩12.9bn	77
Sky Labs	–	71
Medyssey	–	47
InBody	₩17.7bn	29
Finemedix	₩790m	25
Cosmo Robotics	−₩3.3bn	23
Dynamic solution	−₩950m	20
Hironic	₩1.1bn	19

Compare NanoenTek side by side with these companies

NanoenTek DART filings

No filings yet.

Mentioned alongside 2 weeks

NanoenTek FAQ

Who is the CEO of NanoenTek?: According to the DART company overview, NanoenTek's representative director is 정찬일 (name as registered in Korean). The company was founded on 1987-11-18.
Where is NanoenTek listed?: NanoenTek trades on the Korea Exchange KOSDAQ market under the ticker 039860. Its fiscal year ends in December.
What were NanoenTek's latest quarterly results?: In Q2 2026, NanoenTek reported revenue of ₩12.5bn, up 39.4% year on year, and operating profit of ₩687m. Figures come from reports filed on DART.
Does NanoenTek pay a dividend?: NanoenTek did not pay a cash dividend for fiscal 2025, according to its annual report.
Which companies are in the same industry as NanoenTek?: Under the Korean Standard Industrial Classification recorded on DART, NanoenTek is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.